Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Elekta to elect a new board member?

This article was originally published in Clinica

Executive Summary

Jan Secher has been proposed as a member of Swedish firm Elekta's board. Mr Secher is currently president and CEO of industrial service provider Ferrostaal. He has also been operating partner of US private equity fund Apollo, and CEO of molecular diagnostics firm Clarient and SICPA, a specialist in security inks. Stockholm-based Elekta develops devices to treat cancer and brain disorder, including tools and planning systems for radiation therapy and radiosurgery.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT095064

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel